Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Cancer Res. 2016 Mar 4;76(9):2600–2611. doi: 10.1158/0008-5472.CAN-15-1758

Figure 4.

Figure 4

Gβγ subunits activate PAK1 in response to estrogen. (A, B) Combinations of β1, β2, γ2, γ5 and γ13 subunits were overexpressed. E2-dependent PAK1 activation was assessed in the in vitro kinase assay. Both gray bars in B represent the cells treated with HRG. (C) HA-PAK1 was IP’d from PAK1 WT or Y3F clones overexpressing β1γ2 or β1γ5 subunits and immunoblotted.